Advertisement
Research Article Free access | 10.1172/JCI117998
Howard Hughes Medical Institute, Salk Institute, San Diego, California 92186-5800, USA.
Find articles by Prank, K. in: JCI | PubMed | Google Scholar
Howard Hughes Medical Institute, Salk Institute, San Diego, California 92186-5800, USA.
Find articles by Nowlan, S. in: JCI | PubMed | Google Scholar
Howard Hughes Medical Institute, Salk Institute, San Diego, California 92186-5800, USA.
Find articles by Harms, H. in: JCI | PubMed | Google Scholar
Howard Hughes Medical Institute, Salk Institute, San Diego, California 92186-5800, USA.
Find articles by Kloppstech, M. in: JCI | PubMed | Google Scholar
Howard Hughes Medical Institute, Salk Institute, San Diego, California 92186-5800, USA.
Find articles by Brabant, G. in: JCI | PubMed | Google Scholar
Howard Hughes Medical Institute, Salk Institute, San Diego, California 92186-5800, USA.
Find articles by Hesch, R. in: JCI | PubMed | Google Scholar
Howard Hughes Medical Institute, Salk Institute, San Diego, California 92186-5800, USA.
Find articles by Sejnowski, T. in: JCI | PubMed | Google Scholar
Published June 1, 1995 - More info
Recent evidence links osteoporosis, a disease of bone remodeling, to changes in the dynamics of parathyroid hormone secretion. We use nonlinear and linear time series prediction to characterize the secretory dynamics of parathyroid hormone in both healthy human subjects and patients with osteoporosis. Osteoporotic patients appear to lack the periods of high predictability found in normal humans. Our results may provide an explanation for why an intermittent administration of parathyroid hormone is effective in restoring bone mass in osteoporotic patients.
Images.